SAND Sandvik AB (publ)
Sandvik AB (publ), an engineering company, provides products and solutions for mining and rock excavation, metal cutting, and materials technology worldwide. The company offers mining and rock excavation equipment, including drill rigs and bolters, underground loaders and trucks, mechanical cutting equipment, rock tools and rock drills, and mining automation; rock processing equipment, such as crushers, screens, hydraulic breakers, demolition tools, and breaker booms. It provides cutting tools and tooling systems, and digital solutions and software; metal powder for additive manufacturing, and products made from controlled expansion alloys; and tungsten powders, as well as recycling services of secondary tungsten raw materials. It serves aerospace, automotive, mining, general engineering, infrastructure, and other industries. Sandvik AB (publ) was founded in 1862 and is headquartered in Stockholm, Sweden.…
Industry Peers
Specialty Industrial MachineryKey Statistics
About Sandvik (STO: SAND)
›
Sandvik (STO: SAND) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Specialty Industrial Machinery industry, part of the Industrials sector, and reports about 42,831 employees.
The shares were at 336.60 SEK on 19 November 2026, up 16.6% over 52 weeks. Its 52-week range is 272.70 SEK to 413.10 SEK: the price is 18.5% below the high and 23.4% above the low.
At a market capitalisation of 422.23B SEK, it trades at 22.1 times trailing earnings and 24.8 times forward earnings. The median trailing P/E of its 20 largest Specialty Industrial Machinery peers is 29.0, a discount of 24% for SAND. It pays a dividend yielding 1.80% (it pays out 39% of its earnings), against a median of 1.53% among the dividend payers in that peer group.
Sandvik reports return on equity of 15.8%, an operating margin of 19.0% and revenue up 29.1% year over year.
Its debt exceeds its cash by 39.68B SEK, a debt-to-equity ratio of 0.40. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 20 analysts cover the stock, with an average rating of Buy; their mean price target of 402.25 SEK is 19.5% above the current price. The next earnings report is expected on 27 January 2027.